Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19958855 | 0.74 | CA1 (0.33) | — | |
| SCHEMBL9001038 | 0.72 | — | — | |
| SCHEMBL2633080 | 0.70 | CA1 (0.30) | — | |
| SCHEMBL27145192 | 0.70 | CA1 (0.30) | — | |
| SCHEMBL2057315 | 0.70 | — | — | |
| SCHEMBL775845 | 0.68 | CA1 (0.37) | — | |
| Sulfuric Acid SCHEMBL10717113 | 0.68 | CA5A (0.40) | — | |
| Sulfuric Acid SCHEMBL8721086 | 0.68 | CA5A (0.40) | — | |
| SCHEMBL16677044 | 0.68 | — | — | |
| Sulfuric Acid SCHEMBL1889757 | 0.68 | CA5A (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513471-B2 | Process for the manufacture of polyol perfluoropolyether derivative | SOLVAY SOLEXIS S.P.A. (IT) | 2013-08-20 | — | — | US | disclosed |
| US-8513471-B2 | Process for the manufacture of polyol perfluoropolyether derivative | SOLVAY SOLEXIS S.P.A. (IT) | 2013-08-20 | — | — | US | disclosed |
| EP-2197939-B1 | PROCESS FOR THE MANUFACTURE OF POLYOL PERFLUOROPOLYETHER DERIVATIVE | SOLVAY SPECIALTY POLYMERS IT (IT) | 2012-07-11 | — | — | EP | disclosed |
| US-20100240930-A1 | Process for the manufacture of polyol perfluoropolyether derivative | SOLVAY SOLEXIS S.P.A. (IT) | 2010-09-23 | — | — | US | disclosed |
| US-20100240930-A1 | Process for the manufacture of polyol perfluoropolyether derivative | SOLVAY SOLEXIS S.P.A. (IT) | 2010-09-23 | — | — | US | disclosed |
| WO-2009043928-A1 | PROCESS FOR THE MANUFACTURE OF POLYOL PERFLUOROPOLYETHER DERIVATIVE | SOLVAY SOLEXIS S.P.A. (IT) | 2009-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240930-A1 | Process for the manufacture of polyol perfluoropolyether derivative | AFF2, AFF1, AFF4 | F2 7/4885PRSS1 4011/4885PRSS2 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.